<DOC>
	<DOC>NCT02316743</DOC>
	<brief_summary>The purpose of this study is to determine whether levothyroxine supplementation is beneficial in patients with systolic heart failure and subclinical hypothyroidism on the functional class evaluated with a 6 minute walk test.</brief_summary>
	<brief_title>Effects of Levothyroxine Supplementation in Patients With Systolic Heart Failure and Subclinical Hypothyroidism</brief_title>
	<detailed_description>Forty patients with systolic heart failure and subclinical hypothyroidism will be include in a open label trial. They will receive levothyroxine supplementation to determine if their functional class will be affect.</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Hypothyroidism</mesh_term>
	<mesh_term>Heart Failure, Systolic</mesh_term>
	<criteria>Biochemical diagnosis of subclinical hypothyroidism (TSH between 3.5 and 10 with a normal T4) Systolic heart failure with NewYork Heart Association (NYHA) class II or III Left ventricular ejection fraction under 40% Stable heart failure for the past 3 months (no IV furosemide or hospital admission) Betablockers and ACE inhibitors titrated to the maximum tolerated dose Isolated diastolic heart failure Awaiting cardiac resynchronisation therapy Impossibility to perform the 6 minutes walk test Active cancer / Life expectancy under 18 months Treatment with amiodarone</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>